Georgetown Law Open on Time
The Law Center will open on time, Tuesday, January 27, 2015, but liberal leave is in effect.
All designated emergency employees must report to work on time. All other employees may take unscheduled leave, but should contact their supervisor to discuss the needs of their unit and individual circumstances. Classes will begin at their normal time, unless otherwise noted on the class cancellation line: 202-662-9446 or the class cancellation page. Any changes to this announcement will be communicated through the same channels by 5:00 am on Tuesday morning.
Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Adjunct Professor of Law
Patrick Coyne is a trial and appellate attorney. His litigation experience includes patent, trademark, copyright, and trade secret claims; related antitrust and unfair competition issues;...Continue Reading
Patrick Coyne is a trial and appellate attorney. His litigation experience includes patent, trademark, copyright, and trade secret claims; related antitrust and unfair competition issues; and general commercial litigation, products liability, and domestic and international arbitration. He also assists clients with strategic portfolio development and management. Professor Coyne has argued more than 100 cases in state and federal trial and appellate courts, including the U.S. Supreme Court. He has represented clients before the U.S. International Trade Commission; the Patent Trial and Appeal Board of the U.S. Patent Trademark Office (PTAB) (formerly, the U.S. Board of Patent Appeals and Interferences); and the Trademark Trial and Appeal Board. He served as a law clerk and technical advisor to Circuit Judge Edward S. Smith of the U.S. Court of Appeals for the Federal Circuit. Professor Coyne's clients include: United Technologies Corporation, LG Electronics, InterDigital, Gold Peak, FMC, Energy Conversion Devices and Ovonic Battery Company, Ciena, Mobil Oil Corporation, Trex Company, Danaher Corporation, Jacobs Vehicle Systems, Allegheny Teledyne, and Merrell Dow Pharmaceuticals.